News for 'research collaboration'

'Virtual Romance is Too Casual, Risky'

'Virtual Romance is Too Casual, Risky'

Rediff.com9 Aug 2021

50% of respondents believe that romance in the virtual world works well for people who are a little shy/introverted in real life while 50% of respondents in metros feel romance in the virtual world is more flirtatious/casual and generally not serious.

2nd innovation hub in US to strengthen TCS position

2nd innovation hub in US to strengthen TCS position

Rediff.com12 May 2022

IT major Tata Consultancy Services (TCS), in its Q4FY22 results, said the company's banking, finance services and insurance (BFSI) crossed the $10 billion milestone. This includes revenue from financial products, services and platforms. For Suresh Muthuswami, who recently took over as Chairman of North America, one of the focus will be to grow this percentage going ahead. The first step to grow the US market is hiring. Muthuswami said that the company will be hiring more in the US, especially from the campuses. In FY22 TCS hired over 7,000 people in the US and going ahead too the numbers will be similar.

Recruitment for trial of Covaxin in 6-12 age group to start from Tuesday

Recruitment for trial of Covaxin in 6-12 age group to start from Tuesday

Rediff.com14 Jun 2021

In the trial, the vaccine will be given by the intramuscular route in two doses on day 0 and day 28.

How India can NEUTRALISE Enemy Drones

How India can NEUTRALISE Enemy Drones

Rediff.com23 Jul 2021

'An armed helicopter equipped with counter-drone systems will provide the airborne counter-drone capability and flexibility needed to protect India's critical assets.'

Oxford vaccine doing 'everything expected': Study

Oxford vaccine doing 'everything expected': Study

Rediff.com22 Oct 2020

A team at Bristol University used recently developed techniques to validate that the vaccine accurately follows the genetic instructions programmed into it by the Oxford University team.

Centre studies if coronavirus present in Ganga water

Centre studies if coronavirus present in Ganga water

Rediff.com8 Jun 2021

The Centre is conducting a study to assess the presence of SARS-CoV-2, or novel coronavirus, in the Ganga as corpses were found dumped in the river during the second Covid wave, and were fished out from districts in Uttar Pradesh and Bihar, officials said.

Govt developing multi-variant Covid-19 vaccine

Govt developing multi-variant Covid-19 vaccine

Rediff.com14 Sep 2021

Government institutions and pharma industry are examining if a 'cocktail' approach to making a multi-variant Covid-19 vaccine works against multiple strains of the ever-mutating virus, reports Sohini Das.

Cyrus Mistry: The Wise Young Owl

Cyrus Mistry: The Wise Young Owl

Rediff.com9 Sep 2022

'Cyrus was always very different. He would think before acting.'

An interface to detect COVID-19 from CT scans, X-Rays

An interface to detect COVID-19 from CT scans, X-Rays

Rediff.com8 May 2020

AI tech that study CT scans and X-Rays are being deployed as part of global efforts to tackle the coronavirus pandemic, according to LPU researchers. The system may enable doctors and medical staff even in remotest villages of the country to get quick results on the COVID-19 status of a patient.

10 unique skills Indian students MUST have

10 unique skills Indian students MUST have

Rediff.com14 Jan 2020

Teamwork, critical thinking, networking, collaboration and adaptability are among a few soft skills that will enable our students to tackle challenges in life as well as at their workplaces, says Rustom Kerawalla.

India would get COVID-19 vaccine by year-end: Vardhan

India would get COVID-19 vaccine by year-end: Vardhan

Rediff.com24 Aug 2020

Three COVID-19 vaccine candidates, including two indigenous ones, are in different phases of development in India.

Apple creates record, sells nearly 800,000 iPhones in India in Q1

Apple creates record, sells nearly 800,000 iPhones in India in Q1

Rediff.com30 Oct 2020

The US-based company, in collaboration with partners like Wistron and Foxconn, had recently started assembling iPhone 11 in India.

Textile firms get ready to stitch 'anti COVID' clothing line

Textile firms get ready to stitch 'anti COVID' clothing line

Rediff.com1 Aug 2020

To cater to the antiviral fabrics and antimicrobial segment, almost all the Indian big textiles brands, including Reliance, Arvind, Aditya Birla, Donear Group, Raymond, and Siyaram have entered the market. Companies started their journey with reusable masks and PPE kits, and today, they are offering a range of PPE clothing along with fashion and casualwear.

'I never thought that it's a pandemic story'

'I never thought that it's a pandemic story'

Rediff.com7 Sep 2022

'I never thought the European audience will love this film, but we had over 2,000 people at the screening.'

Bharat Biotech seeks emergency nod for use of Covaxin

Bharat Biotech seeks emergency nod for use of Covaxin

Rediff.com8 Dec 2020

Covaxin is being indigenously developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR).

Will India's Covaxin be world's first COVID-19 drug?

Will India's Covaxin be world's first COVID-19 drug?

Rediff.com3 Jul 2020

'We need to prove to the world that quality vaccines and R&D are possible in India.'

Meet Asha, the robotic nurse

Meet Asha, the robotic nurse

Rediff.com17 Dec 2020

'Imagine taking care of a patient who is infected with Covid. A human nurse is unable to do that due to fear of infection. The robot can do that task, while it is controlled or supervised by the human nurse. So the robot becomes an extension of the nurse.'

This path-breaking vaccine may win a Nobel, and it's for not Covid

This path-breaking vaccine may win a Nobel, and it's for not Covid

Rediff.com20 Oct 2021

The new malaria vaccine (RTS.S/ AS01, tentatively brand-named Mosquirix) is the very first one to offer immunity against a parasite -- specifically the plasmodium falciparum parasite, which is the deadliest of the five parasites that cause malaria.

'I am embarrassed about all my films'

'I am embarrassed about all my films'

Rediff.com6 Oct 2022

'Chup is the work that I'm most satisfied with; it won't bore me or make me cringe later.'

Serum Institute to keep 200 mn doses of Covid vaccine ready by Jan

Serum Institute to keep 200 mn doses of Covid vaccine ready by Jan

Rediff.com13 Nov 2020

'SII has started stockpiling the vaccine and now has roughly 40 million doses ready. It is using some of the capacities it had for under development products for the COVID-19 vaccine and by January we will have a capacity to make 100 million doses per month and a stockpile of 200 million doses.'

Phase II human trial of Oxford vaccine begins

Phase II human trial of Oxford vaccine begins

Rediff.com26 Aug 2020

Two male volunteers were administered the vaccine at Bharti Vidyapeeth's Medical College and Hospital, a senior office-bearer of the hospital said.

COVID vaccine likely to be available by first of 2021: Choubey

COVID vaccine likely to be available by first of 2021: Choubey

Rediff.com19 Sep 2020

Responding to another question, Choubey said that the phase-I of clinical trials have revealed excellent safety of the two candidate vaccines indigenously developed by Bharat Biotech in collaboration with Indian Council of Medical Research and Cadila Healthcare Ltd, and now their immunogenicity testing is in progress. Their phase II clinical trials are ongoing.

PM reviews India's COVID-19 vaccination strategy

PM reviews India's COVID-19 vaccination strategy

Rediff.com21 Nov 2020

Modi tweeted that the meeting discussed important issues related to the progress of vaccine development, regulatory approvals and procurement.

PM reviews preparations for vaccination against COVID-19

PM reviews preparations for vaccination against COVID-19

Rediff.com30 Jun 2020

The PM directed officials to evaluate various technology tools to ensure efficient and timely vaccination in due course of time. He also emphasised that detailed planning for such large scale vaccination should be undertaken immediately.

Days after getting Covaxin, Haryana Min tests Covid +ve

Days after getting Covaxin, Haryana Min tests Covid +ve

Rediff.com5 Dec 2020

Anil Vij was administered the trial dose of the indigenous COVID vaccine Covaxin last month

Will 5G turn the tables for India's telecom companies?

Will 5G turn the tables for India's telecom companies?

Rediff.com30 Mar 2022

Consumers can expect a 5G launch in the country soon. Telecom companies (telcos) say if auctions take place on time - the target is July - they would be able to offer some services in a few cities by the end of this year and a full roll-out from 2023. But the question is: will 5G turn the tables for telcos financially? Will average revenue per user (ARPU) improve? Will mobile consumers upgrade to 5G quickly and pay more? Will the expanded functions that 5G enables drum up sufficient revenues? In simple terms, will telcos make more money?

WFH Burnout? 9 Simple Things To Do

WFH Burnout? 9 Simple Things To Do

Rediff.com15 Mar 2022

Clearly demarcate family time in your schedule and ensure that you do not work, receive calls or even reply to emails during this time.

COVID-19's current strain is more infectious than original: Study

COVID-19's current strain is more infectious than original: Study

Rediff.com3 Jul 2020

The researchers said D614G has a small but effective change in the 'spike' protein that protrudes from the surface of the virus, which it uses to enter and infect human cells.

In US, Jaishankar replies to questions on Russian oil import

In US, Jaishankar replies to questions on Russian oil import

Rediff.com12 Apr 2022

India's total purchase of oil from Russia in a month is probably less than what Europe does in an afternoon, External Affairs Minister S Jaishankar said.

Covaxin maker to pay compensation in case of side effects

Covaxin maker to pay compensation in case of side effects

Rediff.com16 Jan 2021

"The compensation for serious adverse event will be paid by sponsor (BBIL) in case if the SAE is proven to be causally related to the vaccine," the consent form said.

Google allows employees to work away from office two days a week

Google allows employees to work away from office two days a week

Rediff.com6 May 2021

Google will move to a hybrid work week, where most Googlers spend approximately three days in the office and two days "wherever they work best", according to a note by Google and Alphabet CEO Sundar Pichai.

Mangalyaan-2 will be an orbiter mission: ISRO chief

Mangalyaan-2 will be an orbiter mission: ISRO chief

Rediff.com20 Feb 2021

As NASA's Perseverance rover landed on Mars to look for signs of past life, ISRO chief K Sivan said India's next mission to the Red Planet is likely to be an orbiter.

Govt clarifies over ICMR's Aug 15 deadline for Covid vaccine

Govt clarifies over ICMR's Aug 15 deadline for Covid vaccine

Rediff.com9 Jul 2020

'Please don't read something which is not there in DG, ICMR's letter. The intent of the letter is only to expedite duly approved clinical trials without compromising on security and safety concerns'

China lands its rover on Mars, creates history

China lands its rover on Mars, creates history

Rediff.com15 May 2021

The rover, Zhurong, named after a god of fire and war in Chinese mythology, landed at the pre-selected area in Utopia Planitia on Mars, the state-run Xinhua news agency reported.

Amid row, ICMR defends COVID-19 vaccine deadline

Amid row, ICMR defends COVID-19 vaccine deadline

Rediff.com4 Jul 2020

ICMR says it is following all globally accepted norms to fast-track vaccine and wants to 'cut red tape'.

With 26,567 new cases, India's Covid tally crosses 97 lakh

With 26,567 new cases, India's Covid tally crosses 97 lakh

Rediff.com8 Dec 2020

The COVID-19 active caseload remained below 4 lakh for the second consecutive day.

Srikant Datar, 2nd Indian to be named Dean of Harvard Business School

Srikant Datar, 2nd Indian to be named Dean of Harvard Business School

Rediff.com10 Oct 2020

Eminent Indian-origin academician Srikant Datar has been named as Dean of Harvard Business School, succeeding Nitin Nohria and becoming the second consecutive dean hailing from India to lead the prestigious 112-year-old institution. Datar, an alumnus of University of Bombay and Indian Institute of Management, Ahmedabad, is the Arthur Lowes Dickinson Professor of Business Administration and the senior associate dean for University Affairs at Harvard Business School (HBS). He will assume charge as the school's next dean on January 1, president Larry Bacow said.

Pursue an international degree in public health in Jaipur

Pursue an international degree in public health in Jaipur

Rediff.com29 Jun 2012

The Johns Hopkins Bloomberg School of Public Health, United States has collaborated with the Indian Institute of Health Management Research in Jaipur to offer a masters programme in public health in the country.

Defence budget raised to Rs 5.25 lakh crore

Defence budget raised to Rs 5.25 lakh crore

Rediff.com1 Feb 2022

In the Union Budget presented in Parliament by Finance Minister Nirmala Sitharaman, a total of Rs 1,52,369 crore has been set aside for capital expenditure that includes purchasing new weapons, aircraft, warships and other military hardware.

J&J seeks permission for trial of 1-shot Covid vaccine in India

J&J seeks permission for trial of 1-shot Covid vaccine in India

Rediff.com20 Apr 2021

The US Food and Drug Administration had in February approved Johnson & Johnson's COVID-19 vaccine that works with just one dose for emergency use.